FilingReader Intelligence

Aurobindo Pharma declares interim dividend, approves Q1 results

August 4, 2025 at 02:09 PM UTC•By FilingReader AI

Aurobindo Pharma declared an interim dividend of INR 4.00 per equity share for the first quarter ended June 30, 2025, with payment by August 21.

The company approved standalone Q1 profit after tax of INR 5,591.3 million and consolidated profit after tax of INR 8,242.0 million.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

The Board of Directors of the Company at its meeting held today, August 4, 2025, has, inter alia, considered and approved: - 1. the standalone and consolidated Unaudited Financial Results ....August 4, 2025 at 01:56 PM UTC

Aurobindo Pharma

BSE:AUROPHARMA•Bombay Stock Exchange

RSS feed for Aurobindo Pharma

News Alerts

Get instant email alerts when Aurobindo Pharma publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →